Corporate Banner
Satellite Banner
qPCR
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Agilent Picks Up Halo Genomics and BioSystem Development

Published: Monday, December 05, 2011
Last Updated: Monday, December 05, 2011
Bookmark and Share
The technologies company is expanding its life sciences business through the acquisition. Halo Genomics provides sample preparation technology for next-generation DNA sequencing, and BioSystem Development develops and manufactures sample prep solutions for drug R&D.

The acquisition of Halo, based in Uppsala, Sweden, is now final. The asset acquisition of BioSystem Development, headquartered in Madison, WI., is expected to be completed by the end of the calendar year.

Halo Genomics' technology addresses sequence-selective sample preparation. The company's HaloPlex technology combines the speed and specificity of PCR-based systems with the scalability and capture-size flexibility of solution-based hybridization formats, thus eliminating the need for library preparation.

HaloPlex technology is expected to complement Agilent's SureSelect target enrichment platform by providing a high-performance solution for small capture sizes. The speed of the technology reportedly addresses the needs of the desktop sequencing market and clinical sequencing space.

"Halo Genomics' unique technology and talented R&D team will expand Agilent's solutions for emerging sequencing applications and accelerate our entry into the rapidly growing next-gen clinical sequencing market," says Gustavo Salem, vp and GM of Agilent's biological systems division within the life sciences group.

BioSystem Development currently supplies Agilent's automation solutions business with AssayMAP cartridges used in conjunction with Agilent's Bravo liquid-handling platform for protein purification and characterization workflows. The combination reportedly enables chromatographic separation with precision flow control.

"We are excited about bringing BioSystem Development, a valued partner, into Agilent," says Fred Strohmeier, vp and GM of Agilent's liquid phase analysis division within the company's life sciences group. "BioSystem Development's innovative and versatile microchromatography technology and the team's applications expertise will help Agilent expand its capabilities as a sample-prep provider for the life sciences market."

The AssayMAP platform can be leveraged for bioprocess development, biomarker identification and analysis, as well as a variety of other life science research applications, according to Agilent.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Agilent Appoints Senior VP and President of Life Sciences and Diagnostics Group
Fred Strohmeier, has been named senior vice president, Agilent, and president of Agilent's Life Sciences and Diagnostics Group (LDG), effective immediately.
Wednesday, December 18, 2013
Princeton Professor Works on Producing a Comprehensive Integrated Biology Database
David Botstein and his colleagues, Joshua Rabinowitz, Benjamin Garcia and Leonid Kruglyak, have received an Agilent Thought Leader Award to support their work in systems biology.
Tuesday, December 14, 2010
Agilent Technologies Collaborates with UC Davis on Breakthrough Food-Safety Research
Technology aims to revolutionize food safety by reducing identification time of food-borne bacteria.
Thursday, December 09, 2010
Agilent and Integrated DNA Technologies Sign Co-Marketing Agreement for qPCR Studies
Partners plan to combine Agilent’s Mx3005P qPCR system and Brilliant qPCR reagents with IDT’s PrimeTime qPCR Assays.
Wednesday, June 16, 2010
Agilent Technologies Announces New Leadership in Biological Systems Division
Company appoints Robert Schueren as VP and GM of Genomics; and John Fjeldsted, Ph.D., as GM of LC/MS.
Wednesday, February 17, 2010
Introduction to Automated Genomic Sample Preparation
A new eSeminar entitled 'Automating Genomics Applications on Bravo Workstations' has been announced by Agilent Automation Solutions.
Wednesday, November 18, 2009
Agilent Expands Life Science Disease Research Portfolio with Eurofins MWG Operon Asset Purchase
The purchase includes the MassCode trademarks and intellectual property, including four families of patents.
Tuesday, November 17, 2009
Agilent Direct Drive Robot Wins Outstanding new Product Award for Laboratory Automation
The direct drive technology combined with VWorks Automation Control software enables best-in-class automation solutions.
Monday, February 09, 2009
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
Genetic Tug of War Before Cells Decide Fate
Researchers report that as developing blood cells are triggered by genetic signals firing on and off, a 'tug of war' occurs.
$1M NIH Grant to Refine PCR Based Cancer Test
Researchers at Cornell University, Weill Cornell Medicine, the University of California, San Francisco, and the Infectious Diseases Institute in Kampala, Uganda, recieve a four-year, $1 million grant to hone technology for a quick, in-the-field diagnosis of Kaposi's sarcoma — a cancer frequently related to HIV infections.
Linkage Biosciences Awarded NHS Contract
Comapny announces that it has been awarded a four-year contract by NHS Blood and Transplant (NHSBT) in the UK for implementation of the LinkSeq™ Real-Time PCR HLA typing product.
Understanding Tumor Evolution
Study provides insight into tumor evolution; may point to improved diagnosis and treatment.
Frankfurter Fraud: Finding Out What’s In Your Hot Dog
Scientists have developed a technique to test the meat content of Frankfurters.
How Cloud Connectivity Can Combat the Reproducibility Crisis
This infographic explains the reproducibility crisis, and how cloud connectivity can help overcome this problem.
Keeping Cells in Shape to Fight Sepsis
Boosting levels of a protein that controls the shape and activity of a crucial group of white blood cells improves survival and recovery chances during sepsis.
This 3D Printer Can Detect Infectious Diseases
Researchers at AI Biosciences, Inc. have repurposed 3D printers into machines capable of performing sample preparation and DNA amplification.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!